Genetic Biomarkers of Barrett's Esophagus Susceptibility and Progression to Dysplasia and Cancer: A Systematic Review and Meta-Analysis.
Findlay JM. et al, (2016), Dig Dis Sci, 61, 25 - 38
Intravenous high-dose interferon with or without maintenance treatment in melanoma at high risk of recurrence: meta-analysis of three trials.
Malczewski A. et al, (2016), Cancer Med, 5, 17 - 23
Diagnosis and treatment of Merkel Cell Carcinoma. European consensus-based interdisciplinary guideline.
Lebbe C. et al, (2015), Eur J Cancer, 51, 2396 - 2403
ONGOING HIGH QUALITY RANDOMISED TRIALS ARE HELPING DEFINE THE ROLE OF RADIOTHERAPY IN MELANOMA
Fogarty G. et al, (2015), Asia-Pacific Journal of Clinical Oncology, 11, 73 - 74
Pragmatic staging of oesophageal cancer using decision theory involving selective endoscopic ultrasonography, PET and laparoscopy.
Findlay JM. et al, (2015), Br J Surg, 102, 1488 - 1499
IGF-1R inhibition induces schedule-dependent sensitization of human melanoma to temozolomide
Macaulay V. et al, (2015), Oncotarget
Attempted validation of the NUn score and inflammatory markers as predictors of esophageal anastomotic leak and major complications.
Findlay JM. et al, (2015), Dis Esophagus, 28, 626 - 633
Attempted validation of the NUn score and inflammatory markers as predictors of esophageal anastomotic leak and major complications
Findlay JM. et al, (2015), Diseases of the Esophagus, 28, 626 - 633
Ipilimumab in the real world: the UK expanded access programme experience in previously treated advanced melanoma patients.
Ahmad SS. et al, (2015), Melanoma Res, 25, 432 - 442
Randomized phase II study evaluating veliparib (ABT-888) with temozolomide in patients with metastatic melanoma.
Middleton MR. et al, (2015), Ann Oncol, 26, 2173 - 2179
O6-methylguanine-DNA methyltransferase in pretreatment tumour biopsies as a predictor of response to temozolomide in melanoma
middleton MR. et al, (2015), British Journal of Cancer
A randomized phase III study comparing dacarbazine, BCNU, cisplatin and tamoxifen with dacarbazine and interferon in advanced melanoma
Middleton M., (2015), British Journal of Cancer
Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guideline.
Stratigos A. et al, (2015), Eur J Cancer, 51, 1989 - 2007
Initial safety results from a multinational, prospective, observational study in advanced melanoma (MEL) (IMAGE)
Middleton M. et al, (2015), EUROPEAN JOURNAL OF CANCER, 51, S678 - S679
Phase I study of two dosing schedules of the investigational oral pan-RAF kinase inhibitor MLN2480 in patients (pts) with advanced solid tumors or melanoma
Rasco DW. et al, (2015), EUROPEAN JOURNAL OF CANCER, 51, S53 - S54
Seropositivity to tumour antigens as a potential new biomarker for melanoma relapse
Clark L. et al, (2015), EUROPEAN JOURNAL OF CANCER, 51, S686 - S686
Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma.
Andtbacka RHI. et al, (2015), J Clin Oncol, 33, 2780 - 2788
Pyrimidine derivatives and guanine derivatives, and their use in treating tumour cells
McMurry TBH. et al, (2015)
A phase I/IIa study of IMCgp100: Partial and complete durable responses with a novel first-in-class immunotherapy for advanced melanoma
Middleton MR. et al, (2015), CANCER RESEARCH, 75